Clinical scoring algorithm for the prescription opioid misuse and abuse questionnaire (POMAQ)

References

• Nahin RL. Estimates of pain prevalence and severity in adults: United States, 2012. J Pain. 2015;16(8):769–780.
   PubMed Web of Science ®Google Scholar
• Paulozzi LJ, Jones C, Mack K, et al. Vital signs: overdoses of prescription opioid pain relievers—United States, 1999–2018. MMWR. 2011;60:1487–1492.
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention (CDC). Prescribing practices: changes in opioid prescribing practices 2019; [cited 2020 September 9]. Available from: https://www.cdc.gov/drugoverdose/data/prescribing/prescribing-practices.html.
   Google Scholar
• Campbell CI, Weisner C, Leresche L, et al. Age and gender trends in long-term opioid analgesic use for noncancer pain. Am J Public Health. 2010;100(12):2541–2547.
   PubMed Web of Science ®Google Scholar
• Carter MW, Yang BK, Davenport M, et al. Increasing rates of opioid misuse among older adults visiting emergency departments. Innov Aging. 2019;3(1):igz002.
   PubMed Web of Science ®Google Scholar
• Weiner SG, El Ibrahimi S, Hendricks MA, et al. Factors associated with opioid overdose after an initial opioid prescription. JAMA Netw Open. 2022;5(1):e2145691.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). Wide-ranging online data for epidemiologic research (WONDER). Atlanta, GA: CDC, National Center for Health Statistics 2016; [cited 2019 July 5]. Available from: http://wonder.cdc.gov.
   Google Scholar
• Institute of Medicine (IOM). Relieving pain in America: a blueprint for transforming prevention, care, education, and research. Washington, D.C.: National Academies Press; 2011.
   Google Scholar
• Food and Drug Administration (FDA). Labeling Supplement and PMR Required 2013; [cited 2018 October 24]. Available from: https://www.fda.gov/downloads/Drugs/DrugSafety/InformationbyDrugClass/UCM367697.pdf.
   Google Scholar
• Coplan PM, Cepeda MS, Petronis KR, et al. Postmarketing studies program to assess the risks and benefits of long-term use of extended-release/long-acting opioids among chronic pain patients. Postgrad Med. 2020;132(1):44–51.
   PubMed Web of Science ®Google Scholar
• Coyne KS, Barsdorf AI, Currie BM, et al. Construct validity and reproducibility of the prescription opioid misuse and abuse questionnaire (POMAQ). Curr Med Res Opin. 2021;37(3):493–503.
   PubMed Web of Science ®Google Scholar
• Coyne KS, Barsdorf AI, Brooks A, et al. Establishing the content validity of the prescription opioid misuse and abuse questionnaire (POMAQ) among chronic pain patients. Curr Med Res Opin. 2021;37(3):505–514.
   PubMed Web of Science ®Google Scholar
• Smith SM, Dart RC, Katz NP, et al. Classification and definition of misuse, abuse, and related events in clinical trials: ACTTION systematic review and recommendations. Pain. 2013;154(11):2287–2296.
   PubMed Web of Science ®Google Scholar
• Spitzer RL. Psychiatric diagnosis: are clinicians still necessary? Compr Psychiatry. 1983;24(5):399–411.
   PubMed Web of Science ®Google Scholar
• Coyne KS, Barsdorf AI, Currie BM, et al. Insight into chronic pain in the United States: descriptive results from the prescription opioid misuse and abuse questionnaire (POMAQ) validation study. Curr Med Res Opin. 2021;37(3):483–492.
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental disorders (5th ed.). Washington, D.C.: APA; 2013.
   Google Scholar
• Manimala YS, Gautam S, Reddy BG. Mass spectrometry: an analytical method. J Pharm Anal. 2016;5(2):118–125.
   Google Scholar
• First MB, Spitzer RL, Gibbon M, et al. Structured clinical interview for DSM-IV® axis I disorders (SCID-I). Clinician version, administration booklet. Washington, D.C.: AMerican Psychiatric Pub Inc. 1997.
   Google Scholar
• Lobbestael J, Leurgans M, Arntz A. Inter-rater reliability of the structured clinical interview for DSM-IV axis I disorders (SCID I) and axis II disorders (SCID II). Clin Psychol Psychother. 2011;18(1):75–79.
   PubMed Web of Science ®Google Scholar
• Skre I, Onstad S, Torgersen S, et al. High interrater reliability for the structured clinical interview for DSM-III-R axis I (SCID-I). Acta Psychiatr Scand. 1991;84(2):167–173.
   PubMed Web of Science ®Google Scholar
• Williams JB, Gibbon M, First MB, et al. The structured clinical interview for DSM-III-R (SCID). II. Multisite test-retest reliability. Arch Gen Psychiatry. 1992;49(8):630–636.
   PubMed Web of Science ®Google Scholar
• Zanarini MC, Frankenburg FR, Hennen J, et al. The longitudinal course of borderline psychopathology: 6-year prospective follow-up of the phenomenology of borderline personality disorder. Am J Psychiatry. 2003;160(2):274–283.
   PubMed Web of Science ®Google Scholar
• Zanarini MC, Skodol AE, Bender D, et al. The collaborative longitudinal personality disorders study: reliability of axis I and II diagnoses. J Pers Disord. 2000;14(4):291–299.
   PubMed Web of Science ®Google Scholar
• Michna E, Ross EL, Hynes WL, et al. Predicting aberrant drug behavior in patients treated for chronic pain: importance of abuse history. J Pain Symptom Manage. 2004;28(3):250–258.
   PubMed Web of Science ®Google Scholar
• Wasan AD, Butler SF, Budman SH, et al. Does report of craving opioid medication predict aberrant drug behavior among chronic pain patients? Clin J Pain. 2009;25(3):193–198.
   PubMed Web of Science ®Google Scholar
• Compton PA, Wu SM, Schieffer B, et al. Introduction of a self-report version of the prescription drug use questionnaire and relationship to medication agreement noncompliance. J Pain Symptom Manage. 2008;36(4):383–395.
   PubMed Web of Science ®Google Scholar
• McHorney CA, Ware JE, Jr, Raczek AE. The MOS 36-Item Short-Form health survey (SF-36): II. psychometric and clinical tests of validity in measuring physical and mental health constructs. Medical Care. 1993;31(3):247–263.
   PubMed Web of Science ®Google Scholar
• Ware JE, Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36): I. conceptual framework and item selection. Medical Care. 1992;30(6):473–483.
   PubMed Web of Science ®Google Scholar
• Hays RD, Hayashi T, Stewart AL. A five-item measure of socially desirable response set. Educ Psychol Meas. 1989;49(3):629–636.
   Web of Science ®Google Scholar
• Cleeland CS, Ryan KM. Pain assessment: global use of the brief pain inventory. Ann Acad Med Singap. 1994;23(2):129–138.
   PubMedGoogle Scholar